Advisory Board Reaches New 52-Week High (ABCO)

NEW YORK ( TheStreet) -- Advisory Board Company (Nasdaq: ABCO) hit a new 52-week high Monday as it is currently trading at $87.88, above its previous 52-week high of $87.56 with 15,512 shares traded as of 10:04 a.m. ET. Average volume has been 105,200 shares over the past 30 days.

Advisory Board has a market cap of $1.3 billion and is part of the services sector and diversified services industry. Shares are up 16.8% year to date as of the close of trading on Friday.

The Advisory Board Company, together with its subsidiaries, engages in the provision of best practices research and analysis, business intelligence and software tools, and management and advisory services primarily in the United States. The company has a P/E ratio of 65.4, below the average diversified services industry P/E ratio of 73.6 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Advisory Board as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full Advisory Board Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

These Are the Biggest Winners and Losers in Activist Investing This Year

These Are the Biggest Winners and Losers in Activist Investing This Year

Elliott Notches Win at Advisory Board, Monitors Progress with NRG - ICYMI

Elliott Notches Win at Advisory Board, Monitors Progress with NRG - ICYMI

Advisory Breaks Up and Sells Following Elliott Campaign

Advisory Breaks Up and Sells Following Elliott Campaign

Wall Street Weighs In on Athenahealth's Strategic Options

Wall Street Weighs In on Athenahealth's Strategic Options

Singer's Elliott Management Eyes 'Strategic Opportunities' at Athenahealth

Singer's Elliott Management Eyes 'Strategic Opportunities' at Athenahealth